Poseida Therapeutics, Inc. ( PSTX) - Key Metrics
Stock symbol PSTX is outdated, potentially delisted? Maybe it is available on other exchange?
PSTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.74 | $0.21 | -$0.10 | -$0.11 |
| 2024Q2 | $0.27 | -$0.32 | $0.40 | $0.39 |
| 2024Q1 | $0.29 | -$0.25 | -$0.16 | -$0.16 |
| 2023Q4 | $0.28 | -$0.27 | -$0.32 | -$0.32 |
| 2023Q3 | $0.10 | -$0.35 | $0.09 | $0.08 |
PSTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | 3.43 |
| 2024Q2 | ? | -2.33 |
| 2024Q1 | ? | -3.07 |
| 2023Q4 | ? | -3.16 |
| 2023Q3 | ? | -1.72 |
PSTX
Price: $9.50
52 week price:
Earnings Per Share: -0.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 268000
Market Capitalization: 927.9 million